Global Interventional Lung Disease Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Interventional Lung Disease Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Bronchoscopes
  • 1.2.2 Respiratory Endotherapy Devices
  • 1.2.3 ENB Systems
  • 1.2.4 Pleuroscopes
  • 1.2.5 Other
• 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Emergency Center
  • 1.3.3 Clinic
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Boston Scientific
  • 2.1.1 Business Overview
  • 2.1.2 Interventional Lung Disease Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Boston Scientific Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Olympus
  • 2.2.1 Business Overview
  • 2.2.2 Interventional Lung Disease Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Olympus Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 FUJIFILM
  • 2.3.1 Business Overview
  • 2.3.2 Interventional Lung Disease Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 FUJIFILM Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Becton, Dickinson and Company
  • 2.4.1 Business Overview
  • 2.4.2 Interventional Lung Disease Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Becton, Dickinson and Company Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Smiths Group
  • 2.5.1 Business Overview
  • 2.5.2 Interventional Lung Disease Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Smiths Group Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Cook Medical
  • 2.6.1 Business Overview
  • 2.6.2 Interventional Lung Disease Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Cook Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Vygon
  • 2.7.1 Business Overview
  • 2.7.2 Interventional Lung Disease Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Vygon Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 PENTAX Medical
  • 2.8.1 Business Overview
  • 2.8.2 Interventional Lung Disease Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 PENTAX Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Clarus Medical
  • 2.9.1 Business Overview
  • 2.9.2 Interventional Lung Disease Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Clarus Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 HUGER Medical Instrument
  • 2.10.1 Business Overview
  • 2.10.2 Interventional Lung Disease Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 HUGER Medical Instrument Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Richard Wolf
  • 2.11.1 Business Overview
  • 2.11.2 Interventional Lung Disease Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Richard Wolf Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Karl Storz
  • 2.12.1 Business Overview
  • 2.12.2 Interventional Lung Disease Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Karl Storz Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Taewoong Medical
  • 2.13.1 Business Overview
  • 2.13.2 Interventional Lung Disease Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Taewoong Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 ELLA - CS
  • 2.14.1 Business Overview
  • 2.14.2 Interventional Lung Disease Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 ELLA - CS Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Interventional Lung Disease Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Interventional Lung Disease Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Interventional Lung Disease Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Interventional Lung Disease Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Interventional Lung Disease Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Interventional Lung Disease Market Analysis by Regions

• 4.1 Global Interventional Lung Disease Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Interventional Lung Disease Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Interventional Lung Disease Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 4.3 Europe Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 4.5 South America Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Interventional Lung Disease Sales and Growth Rate (2014-2019)

5 North America Interventional Lung Disease by Country

• 5.1 North America Interventional Lung Disease Sales, Revenue and Market Share by Country
  • 5.1.1 North America Interventional Lung Disease Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Interventional Lung Disease Revenue and Market Share by Country (2014-2019)
• 5.2 United States Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 5.3 Canada Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 5.4 Mexico Interventional Lung Disease Sales and Growth Rate (2014-2019)

6 Europe Interventional Lung Disease by Country

• 6.1 Europe Interventional Lung Disease Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Interventional Lung Disease Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Interventional Lung Disease Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 6.3 UK Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 6.4 France Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 6.5 Russia Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 6.6 Italy Interventional Lung Disease Sales and Growth Rate (2014-2019)

7 Asia-Pacific Interventional Lung Disease by Country

• 7.1 Asia-Pacific Interventional Lung Disease Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Interventional Lung Disease Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Interventional Lung Disease Revenue and Market Share by Country (2014-2019)
• 7.2 China Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 7.3 Japan Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 7.4 Korea Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 7.5 India Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Interventional Lung Disease Sales and Growth Rate (2014-2019)

8 South America Interventional Lung Disease by Country

• 8.1 South America Interventional Lung Disease Sales, Revenue and Market Share by Country
  • 8.1.1 South America Interventional Lung Disease Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Interventional Lung Disease Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 8.3 Argentina Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 8.4 Colombia Interventional Lung Disease Sales and Growth Rate (2014-2019)

9 Middle East and Africa Interventional Lung Disease by Countries

• 9.1 Middle East and Africa Interventional Lung Disease Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Interventional Lung Disease Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Interventional Lung Disease Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 9.3 Turkey Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 9.4 Egypt Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Interventional Lung Disease Sales and Growth Rate (2014-2019)
• 9.6 South Africa Interventional Lung Disease Sales and Growth Rate (2014-2019)

10 Global Interventional Lung Disease Market Segment by Type

• 10.1 Global Interventional Lung Disease Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Interventional Lung Disease Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Interventional Lung Disease Revenue and Market Share by Type (2014-2019)
• 10.2 Bronchoscopes Sales Growth and Price
  • 10.2.1 Global Bronchoscopes Sales Growth (2014-2019)
  • 10.2.2 Global Bronchoscopes Price (2014-2019)
• 10.3 Respiratory Endotherapy Devices Sales Growth and Price
  • 10.3.1 Global Respiratory Endotherapy Devices Sales Growth (2014-2019)
  • 10.3.2 Global Respiratory Endotherapy Devices Price (2014-2019)
• 10.4 ENB Systems Sales Growth and Price
  • 10.4.1 Global ENB Systems Sales Growth (2014-2019)
  • 10.4.2 Global ENB Systems Price (2014-2019)
• 10.5 Pleuroscopes Sales Growth and Price
  • 10.5.1 Global Pleuroscopes Sales Growth (2014-2019)
  • 10.5.2 Global Pleuroscopes Price (2014-2019)
• 10.6 Other Sales Growth and Price
  • 10.6.1 Global Other Sales Growth (2014-2019)
  • 10.6.2 Global Other Price (2014-2019)

11 Global Interventional Lung Disease Market Segment by Application

• 11.1 Global Interventional Lung Disease Sales Market Share by Application (2014-2019)
• 11.2 Hospital Sales Growth (2014-2019)
• 11.3 Emergency Center Sales Growth (2014-2019)
• 11.4 Clinic Sales Growth (2014-2019)

12 Interventional Lung Disease Market Forecast (2019-2024)

• 12.1 Global Interventional Lung Disease Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Interventional Lung Disease Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Interventional Lung Disease Market Forecast (2019-2024)
  • 12.2.2 Europe Interventional Lung Disease Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Interventional Lung Disease Market Forecast (2019-2024)
  • 12.2.4 South America Interventional Lung Disease Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Interventional Lung Disease Market Forecast (2019-2024)
• 12.3 Interventional Lung Disease Market Forecast by Type (2019-2024)
  • 12.3.1 Global Interventional Lung Disease Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Interventional Lung Disease Market Share Forecast by Type (2019-2024)
• 12.4 Interventional Lung Disease Market Forecast by Application (2019-2024)
  • 12.4.1 Global Interventional Lung Disease Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Interventional Lung Disease Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology